Dhampur Bio Organics Ltd

Q3 FY26Agricultural Food & other Products

Dhampur Bio Organics Q3 FY26: Revenue ₹440.51 Cr, PAT ₹13.87 Cr

Q3 FY26 investor presentation: what the company reported on revenue, margins and projects.

Price₹113

Market cap₹772 Cr

P/E30.2

Updated24 Sept 2026

Read4 min read

Based on Dhampur Bio Organics Ltd's Q3 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.

The short version

Q3FY26 revenue: ₹440.51 Crores, down 9.36% YoY (Q3FY25: ₹486 Crores approx. Q3FY26 EBITDA: ₹47.37 Crores (up from ₹16.85 Crores in Q3FY25) - Q3FY26 EBITDA Margin: 10.75% (up from 3.11% in Q3FY25) - Q3FY26 PAT: ₹13.87 Crores (up from -₹6.21 Crores in Q3FY25) - Q3FY26 PAT Margin: 3.15% (improved from -1.28% in Q3FY25) - Revenue for Q3FY26 declined by 9.36% YoY to ₹440.51 Crores, mainly due to lower sugar sales volume.

From Dhampur Bio Organics Ltd's Q3 FY26 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

Q3FY26 revenue: ₹440.51 Crores, down 9.36% YoY (Q3FY25: ₹486 Crores approx. net of excise).
Sugar segment revenue: ₹376.44 Crores, down 20.50% YoY.
Sugar sales volume: 73,282 tons in Q3FY26, down from 89,252 tons in Q3FY25.
Sugar average realization increased by 6.72% YoY to ₹41,316/ton in Q3FY26.
Biofuel & Spirits revenue: ₹83.02 Crores, down 9.49% YoY.
Biofuel & Spirits ethanol production decreased (e.g., 14.45 Mn BL Q3FY26 vs 15.60 Mn BL Q3FY25).

2 more points management made on revenue & sales performance

Profitability & Margins

Q3FY26 EBITDA: ₹47.37 Crores (up from ₹16.85 Crores in Q3FY25)
Q3FY26 EBITDA Margin: 10.75% (up from 3.11% in Q3FY25)
Q3FY26 PAT: ₹13.87 Crores (up from -₹6.21 Crores in Q3FY25)
Q3FY26 PAT Margin: 3.15% (improved from -1.28% in Q3FY25)
Revenue for Q3FY26 declined by 9.36% YoY to ₹440.51 Crores, mainly due to lower sugar sales volume.

2 more points management made on profitability & margins

See what Dhampur Bio Organics Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The presentation does not explicitly mention any specific capex amounts, capacity expansion plans, or new plant/projects with detailed status or timelines. However, it includes the following relevant points: - Focus on enhancing packaged sugar capacity at the Asmoli plant as part of sugar premiumization strategy (Page 9). - Transformation towards manufacturing niche, processed, value-added sugar including pharma-grade sugar production (Page 9).

- Existing manufacturing capacities across 3 plants (Asmoli, Mansurpur, Meerganj) for sugar, biofuels, spirits, power, etc., but no announced expansions or new plants listed (Page 6). - No explicit capital expenditure figures or timelines for expansions or new projects mentioned anywhere in the presentation. In summary, the presentation highlights strategic focus areas but does not disclose specific capex, capacity expansion amounts, or project timelines.

2 more points management made on capital expenditure plans

Top-ranked in Agricultural Food & other Products

Ranked on what management guided this quarter

5x potential

1Regaal Resources₹927 Cr

Rev 1Mar 2

2Prospect Consum.₹21 Cr

Rev 1Mar 3

3₹250 Cr

Rev 2Mar 1

4₹218 Cr

Rev 2Mar 1

5₹2.7K Cr

Rev 2Mar 2

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

On Page 25, the presentation notes the company repaid long-term loans of ₹17.59 crores during Q3 FY25.
Long term loans as of December 31, 2025, stand at ₹269 crores (down from ₹309 crores as of March 31, 2025).
Net working capital (net) was ₹357 crores as of December 31, 2025 (compared to ₹837 crores as of March 31, 2025).
The long-term debt to equity ratio improved slightly from 0.30 (March 31, 2025) to 0.27 (December 31, 2025).

2 more points management made on fundraising & capital structure

See what Dhampur Bio Organics Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The investor presentation for Dhampur Bio Organics Limited does not report or mention any details related to: - Order book - Order inflow - Pending orders The presentation primarily covers operational highlights, financial performance, segmental details, ESG strategy, shareholder information, and company contact details without any reference to order book or pending orders.

Dhampur Bio Organics Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Reported quarterly figures (₹ Cr). Latest: revenue ₹486 Cr, net profit ₹17 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Dhampur Bio Organics Ltd's management said in earlier quarters

Others in Agricultural Food & other Products this season

Magadh Sugar & Energy Ltd (Q3 FY26)
Revenue for Q3FY26 was Rs 297 Cr, up from Rs 285 Cr in Q3FY25, indicating a ~4.2% YoY increase. Key concall takeaways from Magadh Sugar & Energy Ltd's Q3 FY26…
Dwarikesh Sugar Industries Ltd (Q3 FY26)
Sugar sold: 5.20 lakh quintals vs 4.99 lakh quintals (+4%) . Key concall takeaways from Dwarikesh Sugar Industries Ltd's Q3 FY26 earnings call — and how it…
Dhampur Sugar Mills Ltd (Q3 FY26)
667.4 Crore vs. Key concall takeaways from Dhampur Sugar Mills Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.
Avadh Sugar & Energy Ltd (Q3 FY26)
Revenue for Q3FY26: Rs 639.16 Cr, up from Rs 618.52 Cr in Q3FY25 (approx. Key concall takeaways from Avadh Sugar & Energy Ltd's Q3 FY26 earnings call — and how…

Compare:vs Marico vs Tata Consumer Products Ltd vs Patanjali Foods

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Dhampur Bio Organics Ltd Q3 FY26 results?

What is Dhampur Bio Organics Ltd share price analysis?

Dhampur Bio Organics Ltd currently shows a neutral. The stock trades at a P/E of 30.2 with a market cap of ₹772 Cr. Investors should review the full earnings analysis for detailed insights.

Is Dhampur Bio Organics Ltd planning capital expenditure?

The presentation does not explicitly mention any specific capex amounts, capacity expansion plans, or new plant/projects with detailed status or timelines.

Keep Dhampur Bio Organics Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.